Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$412M |
| 2 |
Advanced Micro Devices
AMD
|
+$294M |
| 3 |
Apple
AAPL
|
+$244M |
| 4 |
Qualcomm
QCOM
|
+$207M |
| 5 |
Pinduoduo
PDD
|
+$180M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$510M |
| 2 |
Uber
UBER
|
+$419M |
| 3 |
Chevron
CVX
|
+$286M |
| 4 |
Meta Platforms (Facebook)
META
|
+$255M |
| 5 |
NVO
Novo Nordisk
NVO
|
+$215M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.64% |
| 2 | Healthcare | 18.28% |
| 3 | Consumer Discretionary | 13.73% |
| 4 | Industrials | 8.66% |
| 5 | Financials | 7.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
THRD
2101
DELISTED
Third Harmonic Bio
THRD
| $1.43M | ﹤0.01% |
110,200
+41,900
| +61% | +$518K |
|
2102
Prosperity Bancshares
PB
$8.97B
| $1.43M | ﹤0.01% |
23,372
-43,800
| -65% | -$2.7M |
|
2103
Data I/O
DAIO
$29.2M
| $1.43M | ﹤0.01% |
517,543
-10,055
| -2% | -$31.2K |
|
|
FNGA
2104
DELISTED
MicroSectors FANG+ Index 3X Leveraged ETNs due January 8, 2038
FNGA
| $1.42M | ﹤0.01% |
3,200
-600
| -16% | -$211K |
|
|
GPGI
2105
GPGI Inc
GPGI
$3.83B
| $1.42M | ﹤0.01% |
252,104
+157,108
| +165% | +$868K |
|
2106
OptimizeRx
OPRX
$114M
| $1.42M | ﹤0.01% |
142,146
+71,700
| +102% | +$788K |
|
2107
United Fire Group
UFCS
$1.32B
| $1.42M | ﹤0.01% |
65,983
-36,355
| -36% | -$804K |
|
2108
Aware
AWRE
$26M
| $1.41M | ﹤0.01% |
717,773
+25,800
| +4% | +$47.8K |
|
2109
WesBanco
WSBC
$3.97B
| $1.41M | ﹤0.01% |
50,525
+15,000
| +42% | +$415K |
|
|
NSA
2110
DELISTED
National Storage Affiliates Trust
NSA
| $1.41M | ﹤0.01% |
34,100
-50,300
| -60% | -$1.9M |
|
2111
Village Farms International
VFF
$234M
| $1.4M | ﹤0.01% |
1,374,771
+766,205
| +126% | +$932K |
|
2112
Structure Therapeutics
GPCR
$3.41B
| $1.4M | ﹤0.01% |
+35,700
| New | +$1.47M |
|
|
IAUX
2113
i-80 Gold Corp
IAUX
$1.11B
| $1.4M | ﹤0.01% |
+1,296,900
| New | +$1.52M |
|
2114
Vanguard S&P 500 Growth ETF
VOOG
$25.9B
| $1.4M | ﹤0.01% |
25,200
-20,400
| -45% | -$1.06M |
|
2115
Vanguard FTSE Emerging Markets ETF
VWO
$121B
| $1.4M | ﹤0.01% |
+31,909
| New | +$1.37M |
|
2116
Timken Company
TKR
$9.56B
| $1.39M | ﹤0.01% |
+17,400
| New | +$1.5M |
|
2117
Global X SuperDividend ETF
SDIV
$1.22B
| $1.39M | ﹤0.01% |
+63,000
| New | +$1.39M |
|
2118
iShares Core Dividend Growth ETF
DGRO
$42.7B
| $1.38M | ﹤0.01% |
24,000
-31,500
| -57% | -$1.8M |
|
2119
Concrete Pumping Holdings
BBCP
$490M
| $1.38M | ﹤0.01% |
229,500
-88,687
| -28% | -$612K |
|
2120
Braskem
BAK
$928M
| $1.38M | ﹤0.01% |
213,700
-232,600
| -52% | -$1.85M |
|
2121
Remitly
RELY
$4.79B
| $1.38M | ﹤0.01% |
113,500
-11,300
| -9% | -$175K |
|
2122
Princeton Bancorp
BPRN
$281M
| $1.37M | ﹤0.01% |
41,523
+1,800
| +5% | +$54.5K |
|
2123
Cushman & Wakefield Ltd
CWK
$3.14B
| $1.37M | ﹤0.01% |
132,100
-282,400
| -68% | -$2.92M |
|
|
DDL
2124
Dingdong
DDL
$562M
| $1.37M | ﹤0.01% |
690,200
+267,700
| +63% | +$448K |
|
2125
Treace Medical Concepts
TMCI
$280M
| $1.37M | ﹤0.01% |
206,500
+29,100
| +16% | +$235K |
|
Similar funds
Renaissance Technologies's Q2 2024 Portfolio in Review
As of Q2 2024, Renaissance Technologies held 4,123 positions worth $59B, down 7.3% from $63.6B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies withdrew a net $4.49B in Q2 2024, closing 675 positions and reducing 1,503 holdings. Its most notable exit was Bank of America, an estimated $142M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in Broadcom worth $472M.
- Renaissance Technologies's largest Q2 2024 buy was Broadcom: 2,941,150 shares worth $472M.
- Renaissance Technologies added most to Apple in Q2 2024, an estimated $244M increase.
- Renaissance Technologies's biggest Q2 2024 reduction was Amazon, cutting an estimated $510M.
- Renaissance Technologies fully exited Bank of America in Q2 2024, selling an estimated $142M.
- Renaissance Technologies's ten largest holdings make up 12% of its $59B portfolio in Q2 2024.
- Renaissance Technologies opened 463 new positions and closed 675 in Q2 2024.
- Renaissance Technologies's portfolio value fell 7.3% quarter-over-quarter to $59B.
Based on Renaissance Technologies's 13F filing for Q2 2024, filed 9 Aug 2024.